Left atrial appendage closure: Six reasons why I wouldn't choose a percutaneous closure for my appendage

Marco Ferlini, Roberta Rossini

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Left atrial appendage has been shown as a primary source of thrombi in patients with non-valvular atrial fibrillation (AF). Non vitamin k oral anticoagulants (NOAC) have been shown to be safe and effective in the prevention of embolic complications. Current guidelines on AF state that percutaneous left atrial appendage closure (LAAC) might be considered in patients with contraindication to long term oral anticoagulant therapy (OAC). An overview of the main trials on NOAC and LAAC is provided.

Original languageEnglish
Pages (from-to)42-44
Number of pages3
JournalInternational Journal of Cardiology
Volume251
DOIs
Publication statusPublished - Jan 15 2018

Fingerprint

Atrial Appendage
Anticoagulants
Vitamins
Atrial Fibrillation
Thrombosis
Guidelines
Therapeutics

Keywords

  • Atrial fibrillation
  • Left atrial appendage closure
  • NOAC

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Left atrial appendage closure : Six reasons why I wouldn't choose a percutaneous closure for my appendage. / Ferlini, Marco; Rossini, Roberta.

In: International Journal of Cardiology, Vol. 251, 15.01.2018, p. 42-44.

Research output: Contribution to journalArticle

@article{a0502a4ca1e548f1b97f03a12afc4672,
title = "Left atrial appendage closure: Six reasons why I wouldn't choose a percutaneous closure for my appendage",
abstract = "Left atrial appendage has been shown as a primary source of thrombi in patients with non-valvular atrial fibrillation (AF). Non vitamin k oral anticoagulants (NOAC) have been shown to be safe and effective in the prevention of embolic complications. Current guidelines on AF state that percutaneous left atrial appendage closure (LAAC) might be considered in patients with contraindication to long term oral anticoagulant therapy (OAC). An overview of the main trials on NOAC and LAAC is provided.",
keywords = "Atrial fibrillation, Left atrial appendage closure, NOAC",
author = "Marco Ferlini and Roberta Rossini",
year = "2018",
month = "1",
day = "15",
doi = "10.1016/j.ijcard.2017.09.015",
language = "English",
volume = "251",
pages = "42--44",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Left atrial appendage closure

T2 - Six reasons why I wouldn't choose a percutaneous closure for my appendage

AU - Ferlini, Marco

AU - Rossini, Roberta

PY - 2018/1/15

Y1 - 2018/1/15

N2 - Left atrial appendage has been shown as a primary source of thrombi in patients with non-valvular atrial fibrillation (AF). Non vitamin k oral anticoagulants (NOAC) have been shown to be safe and effective in the prevention of embolic complications. Current guidelines on AF state that percutaneous left atrial appendage closure (LAAC) might be considered in patients with contraindication to long term oral anticoagulant therapy (OAC). An overview of the main trials on NOAC and LAAC is provided.

AB - Left atrial appendage has been shown as a primary source of thrombi in patients with non-valvular atrial fibrillation (AF). Non vitamin k oral anticoagulants (NOAC) have been shown to be safe and effective in the prevention of embolic complications. Current guidelines on AF state that percutaneous left atrial appendage closure (LAAC) might be considered in patients with contraindication to long term oral anticoagulant therapy (OAC). An overview of the main trials on NOAC and LAAC is provided.

KW - Atrial fibrillation

KW - Left atrial appendage closure

KW - NOAC

UR - http://www.scopus.com/inward/record.url?scp=85035772298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035772298&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2017.09.015

DO - 10.1016/j.ijcard.2017.09.015

M3 - Article

AN - SCOPUS:85035772298

VL - 251

SP - 42

EP - 44

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

ER -